Click here to learn more >>We understand that evaluating new biomanufacturing technologies that promise efficiency gains is challenging. That’s why we are demonstrating our mAb process that tested the performance of a new Xcellerex automatic perfusion system (APS) bioreactor, compared resin and fiber-based chromatography, and utilized sensor technology—all in a production environment that was closed and connected.
November 19, 2020